Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice

Pflugers Archiv European Journal of Physiology

Volumn 467, Issue 6, 2015, Pages 1303-1317

  Najafi, Aref ^a,f   Schlossarek, Saskia ^b,c   van Deel, Elza D ^a,d   van den Heuvel, Nikki ^a   Güçlü, Ahmet ^e,f   Goebel, Max ^a   Kuster, Diederik W D ^a,g   Carrier, Lucie ^b,c   van der Velden, Jolanda ^a,f  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^g LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Cardiac myosin binding protein C; Exercise; Hypertrophic cardiomyopathy; Sex differences

Indexed keywords

CALCIUM; CARRIER PROTEIN; MYOSIN-BINDING PROTEIN C; TROPONIN I;

ADAPTATION; ANIMAL; CELL CULTURE; EXERCISE; FEMALE; GENETICS; HEART CONTRACTION; HEART MUSCLE CELL; HYPERTROPHIC CARDIOMYOPATHY; MALE; METABOLISM; MOUSE; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; SEX DIFFERENCE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CALCIUM; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; CELLS, CULTURED; FEMALE; MALE; MICE; MUTATION; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PHYSICAL EXERTION; SEX FACTORS; TROPONIN I;

EID: 84939892990     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-014-1570-7     Document Type: Article

References (64)

1. Alcalai R, Seidman JG, Seidman CE (2008) Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol 19:104–110
2. Barefield D, Kumar M, de Tombe PP et al (2014) Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 306:H807–H815
3. Baudenbacher F, Schober T, Pinto JR et al (2008) Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. J Clin Invest 118:3893–3903
4. Berul CI, Christe ME, Aronovitz MJ et al (1998) Familial hypertrophic cardiomyopathy mice display gender differences in electrophysiological abnormalities. J Interv Card Electrophysiol 2:7–14
5. Borbely A, van der Velden J, Papp Z et al (2005) Cardiomyocyte stiffness in diastolic heart failure. Circulation 111:774–781
6. Carrier L, Knoll R, Vignier N et al (2004) Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice. Cardiovasc Res 63:293–304
7. Cheng Y, Wan X, McElfresh TA et al (2013) Impaired contractile function due to decreased cardiac myosin binding protein C content in the sarcomere. Am J Physiol Heart Circ Physiol 305:H52–H65
8. Christiaans I, Birnie E, van Langen IM et al (2010) The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening. Eur Heart J 31:842–848
9. De Bono JP, Adlam D, Paterson DJ et al (2006) Novel quantitative phenotypes of exercise training in mouse models. Am J Physiol Regul Integr Comp Physiol 290:R926–R934
10. de Waard MC, van der Velden J, Bito V et al (2007) Early exercise training normalizes myofilament function and attenuates left ventricular pump dysfunction in mice with a large myocardial infarction. Circ Res 100:1079–1088
11. Diffee GM, Seversen EA (1985) Titus MM (2001) Exercise training increases the Ca(2+) sensitivity of tension in rat cardiac myocytes. J Appl Physiol 91:309–315
12. Elliott PM, Poloniecki J, Dickie S et al (2000) Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36:2212–2218
13. Fitzsimons DP, Bodell PW, Baldwin KM (1989) Phosphorylation of rodent cardiac myosin light chain 2: effects of exercise. J Appl Physiol 67:2447–2453, 1985
14. Foryst-Ludwig A, Kreissl MC, Sprang C et al (2011) Sex differences in physiological cardiac hypertrophy are associated with exercise-mediated changes in energy substrate availability. Am J Physiol Heart Circ Physiol 301:H115–H122
15. Fraysse B, Weinberger F, Bardswell SC et al (2012) Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice. J Mol Cell Cardiol 52:1299–1307
16. Hamdani N, Kooij V, van Dijk S et al (2008) Sarcomeric dysfunction in heart failure. Cardiovasc Res 77:649–658
17. Harris SP, Bartley CR, Hacker TA et al (2002) Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. Circ Res 90:594–601
18. Hernandez OM, Szczesna-Cordary D, Knollmann BC et al (2005) F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers. J Biol Chem 280:37183–37194
19. Hershberger RE, Cowan J, Morales A et al (2009) Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail 2:253–261
20. Ho CY, Sweitzer NK, McDonough B et al (2002) Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 105:2992–2997
21. Hoskins AC, Jacques A, Bardswell SC et al (2010) Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy. J Mol Cell Cardiol 49:737–745
22. Jacques A, Hoskins AC, Kentish JC et al (2008) From genotype to phenotype: a longitudinal study of a patient with hypertrophic cardiomyopathy due to a mutation in the MYBPC3 gene. J Muscle Res Cell Motil 29:239–246
23. Konhilas JP, Maass AH, Luckey SW et al (2004) Sex modifies exercise and cardiac adaptation in mice. Am J Physiol Heart Circ Physiol 287:H2768–H2776
24. Konhilas JP, Watson PA, Maass A et al (2006) Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy. Circ Res 98:540–548
25. Kooij V, Saes M, Jaquet K et al (2010) Effect of troponin I Ser23/24 phosphorylation on Ca2+-sensitivity in human myocardium depends on the phosphorylation background. J Mol Cell Cardiol 48:954–963
26. Kubo T, Kitaoka H, Okawa M et al (2010) Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based Japanese population: results from Kochi RYOMA study. J Cardiol 56:314–319
27. Leite-Moreira AF (2006) Current perspectives in diastolic dysfunction and diastolic heart failure. Heart 92:712–718
28. Lin CL, Chiang CW, Shaw CK et al (1999) Gender differences in the presentation of adult obstructive hypertrophic cardiomyopathy with resting gradient: a study of 122 patients. Jpn Circ J 63:859–864
29. Maass AH, Ikeda K, Oberdorf-Maass S et al (2004) Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Circulation 110:2102–2109
30. Maron BJ (2002) Hypertrophic cardiomyopathy: a systematic review. JAMA 287:1308–1320
31. Maron BJ, Doerer JJ, Haas TS et al (2009) Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation 119:1085–1092
32. Maron BJ, Roberts WC, Epstein SE (1982) Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation 65:1388–1394
33. Maron BJ, Towbin JA, Thiene G et al (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807–1816
34. McConnell BK, Fatkin D, Semsarian C et al (2001) Comparison of two murine models of familial hypertrophic cardiomyopathy. Circ Res 88:383–389
35. McKee LA, Chen H, Regan JA et al (2013) Sexually dimorphic myofilament function and cardiac troponin I phosphospecies distribution in hypertrophic cardiomyopathy mice. Arch Biochem Biophys 535:39–48
36. McKenna WJ, England D, Doi YL et al (1981) Arrhythmia in hypertrophic cardiomyopathy. I: influence on prognosis. Br Heart J 46:168–172
37. Michels M, Soliman OI, Kofflard MJ et al (2009) Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations. JACC Cardiovasc Imaging 2:58–64
38. Morganroth J, Maron BJ, Henry WL et al (1975) Comparative left ventricular dimensions in trained athletes. Ann Intern Med 82:521–524
39. Nguyen L, Chung J, Lam L et al (2007) Abnormal cardiac response to exercise in a murine model of familial hypertrophic cardiomyopathy. Int J Cardiol 119:245–248
40. Olivotto I, Maron MS, Adabag AS et al (2005) Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol 46:480–487
41. Olsson MC, Palmer BM, Leinwand LA et al (2001) Gender and aging in a transgenic mouse model of hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 280:H1136–H1144
42. O’Mahony C, Elliott P, McKenna W (2012) Sudden cardiac death in hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol 6:443–451
43. Page SP, Kounas S, Syrris P et al (2012) Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome. Circ Cardiovasc Genet 5:156–166
44. Palmer BM, Wang Y, Teekakirikul P et al (2008) Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex. Am J Physiol Heart Circ Physiol 294:H1939–H1947
45. Pelliccia A, Fagard R, Bjornstad HH et al (2005) Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 26:1422–1445
46. Poutanen T, Tikanoja T, Jaaskelainen P et al (2006) Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes. Am Heart J 151:725 e1–725 e9
47. Regitz-Zagrosek V, Oertelt-Prigione S, Seeland U et al (2010) Sex and gender differences in myocardial hypertrophy and heart failure. Circ J 74:1265–1273
48. Richard P, Charron P, Carrier L et al (2003) Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107:2227–2232
49. Schaible TF, Penpargkul S, Scheuer J (1981) Cardiac responses to exercise training in male and female rats. J Appl Physiol Respir Environ Exerc Physiol 50:112–117
50. Schober T, Huke S, Venkataraman R et al (2012) Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia. Circ Res 111:170–179
51. Sequeira V, Wijnker PJ, Nijenkamp LL et al (2013) Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations. Circ Res 112:1491–1505
52. Stohr A, Friedrich FW, Flenner F et al (2013) Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice. J Mol Cell Cardiol 63:189–198
53. van Deel ED, de Boer M, Kuster DW et al (2011) Exercise training does not improve cardiac function in compensated or decompensated left ventricular hypertrophy induced by aortic stenosis. J Mol Cell Cardiol 50:1017–1025
54. van der Velden J, Boontje NM, Papp Z et al (2002) Calcium sensitivity of force in human ventricular cardiomyocytes from donor and failing hearts. Basic Res Cardiol 97(Suppl 1):I118–I126
55. van Dijk SJ, Boontje NM, Heymans MW et al (2013) Preserved cross-bridge kinetics in human hypertrophic cardiomyopathy patients with MYBPC3 mutations. Pflugers Arch
56. van Dijk SJ, Dooijes D, dos Remedios C et al (2009) Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation 119:1473–1483
57. van Dijk SJ, Paalberends ER, Najafi A et al (2012) Contractile dysfunction irrespective of the mutant protein in human hypertrophic cardiomyopathy with normal systolic function. Circ Heart Fail 5:36–46
58. Varnava AM, Elliott PM, Sharma S et al (2000) Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84:476–482
59. Vignier N, Schlossarek S, Fraysse B et al (2009) Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice. Circ Res 105:239–248
60. Warren SA, Briggs LE, Zeng H et al (2012) Myosin light chain phosphorylation is critical for adaptation to cardiac stress. Circulation 126:2575–2588
61. Wijnker PJ, Foster DB, Tsao AL et al (2013) Impact of site-specific phosphorylation of protein kinase A sites Ser23 and Ser24 of cardiac troponin I in human cardiomyocytes. Am J Physiol Heart Circ Physiol 304:H260–H268
62. Wisloff U, Loennechen JP, Currie S et al (2002) Aerobic exercise reduces cardiomyocyte hypertrophy and increases contractility, Ca2+ sensitivity and SERCA-2 in rat after myocardial infarction. Cardiovasc Res 54:162–174
63. Witjas-Paalberends ER, Piroddi N, Stam K et al (2013) Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy. Cardiovasc Res 99:432–441
64. Zaremba R, Merkus D, Hamdani N et al (2007) Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies. Proteomics Clin Appl 1:1285–1290